Skye Bioscience, Inc. Derivative Liability, Current
Skye Bioscience, Inc. (SKYE) had Derivative Liability, Current of $3 as of 2022-12-31, per its 10-K filed 2024-03-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2024-03-22
- 2022-12-31: Derivative Liability, Current $3.00.
- 2022-09-30: Derivative Liability, Current $326.00.
- 2022-06-30: Derivative Liability, Current $6.55K.
- 2022-03-31: Derivative Liability, Current $16.08K.
| Period end | Derivative Liability, Current |
|---|---|
| 2022-12-31 | $3.00 10-K · filed 2024-03-22 |
| 2022-09-30 | $326.00 10-Q · filed 2023-11-14 |
| 2022-06-30 | $6.55K 10-Q · filed 2023-08-07 |
| 2022-03-31 | $16.08K 10-Q · filed 2023-05-12 |
| 2021-12-31 | $59.73K 10-K · filed 2024-03-22 |
| 2021-09-30 | $207.92K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $397.56K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $276.92K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $38.57K 10-K · filed 2023-03-31 |
| 2020-09-30 | $41.15K 10-Q · filed 2021-11-10 |
| 2020-06-30 | $465.29K 10-Q · filed 2021-08-06 |
| 2020-03-31 | $248.05K 10-Q · filed 2021-05-07 |
| 2019-12-31 | $410.60K 10-K · filed 2022-03-28 |
| 2019-09-30 | $13.74M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $10.66M 10-Q · filed 2020-08-13 |
| 2019-03-31 | $28.33M 10-Q · filed 2020-05-08 |
| 2018-12-31 | $15.74M 10-K · filed 2021-03-02 |
| 2018-09-30 | $11.11M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $10.09M 10-Q · filed 2019-08-09 |
| 2018-03-31 | $8.59M 10-Q · filed 2019-05-10 |
| 2017-12-31 | $271.71K 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |